Company · ALT
Altimmune, Inc.
Nasdaq's symbol directory lists ALT on Nasdaq as “Altimmune, Inc. - Common Stock”.
In the 12 months to Nov 8, 2026: insiders bought on 1 occasion ($44K); 3 company reports (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Durso Jerome Benedict, President and CEO bought $44K
Every trade (1)
- BUYDurso Jerome Benedict, President and CEO bought $44K
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Creation of a direct financial obligation Oct 29, 2026
- Departure or appointment of directors or officers; Regulation FD disclosure Oct 27, 2026
- Departure or appointment of directors or officers Sep 29, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.